Orgenesis Inc.
ORGS
$2.27
-$0.0525-2.26%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 347.00K | 246.00K | 141.00K | 165.00K | 110.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 347.00K | 246.00K | 141.00K | 165.00K | 110.00K |
| Cost of Revenue | 585.00K | 538.00K | 492.00K | 162.00K | 139.00K |
| Gross Profit | -238.00K | -292.00K | -351.00K | 3.00K | -29.00K |
| SG&A Expenses | 2.66M | 2.06M | 6.06M | 2.15M | 1.25M |
| Depreciation & Amortization | 196.00K | 226.00K | 153.00K | 153.00K | 153.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.97M | 4.31M | 9.07M | 5.47M | 2.35M |
| Operating Income | -7.62M | -4.07M | -8.93M | -5.30M | -2.24M |
| Income Before Tax | -9.23M | -9.36M | -9.99M | -6.76M | -3.33M |
| Income Tax Expenses | 32.00K | 5.00K | 16.00K | -141.00K | 394.00K |
| Earnings from Continuing Operations | -9.27M | -9.37M | -10.01M | -6.62M | -3.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 146.00K | 462.00K | 240.00K | 0.00 | -- |
| Net Income | -9.12M | -8.90M | -9.77M | -6.62M | -3.73M |
| EBIT | -7.62M | -4.07M | -8.93M | -5.30M | -2.24M |
| EBITDA | -7.08M | -3.36M | -8.55M | -5.11M | -2.04M |
| EPS Basic | -1.93 | -2.29 | -2.94 | -2.21 | -1.24 |
| Normalized Basic EPS | -1.09 | -1.36 | -1.77 | -0.70 | -0.69 |
| EPS Diluted | -1.93 | -2.29 | -2.94 | -2.21 | -1.24 |
| Normalized Diluted EPS | -1.09 | -1.36 | -1.77 | -0.70 | -0.69 |
| Average Basic Shares Outstanding | 4.72M | 3.89M | 3.32M | 3.00M | 3.00M |
| Average Diluted Shares Outstanding | 4.72M | 3.89M | 3.32M | 3.00M | 3.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |